The prevalence of obesity is increased in patients with late compared with early onset psoriasis

Annals of Epidemiology

Volumn 23, Issue 11, 2013, Pages 688-692

  Herédi, Emese ^a   Csordás, Anikó ^a   Clemens, Marcell ^a   Ádám, Balázs ^a   Gáspár, Krisztián ^a   Törocsik, Dániel ^a   Nagy, Georgina ^a   Ádány, Róza ^a   Gaál, János ^b   Remenyik, Éva ^a   Szegedi, Andrea ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Kenezy Korhaz Rendelointezet   (Hungary)

Author keywords

Age of onset; Comorbidity; Psoriasis

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; EARLY ONSET PSORIASIS; FAMILY HISTORY; FEMALE; HUMAN; LATE ONSET PSORIASIS; MAJOR CLINICAL STUDY; MALE; OBESITY; ONSET AGE; POTENTIAL DIFFERENCE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; WAIST CIRCUMFERENCE;

AGE OF ONSET; COMORBIDITY; PSORIASIS;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AGED; BODY MASS INDEX; COMORBIDITY; FEMALE; HUMANS; HUNGARY; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; PREVALENCE; PSORIASIS; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WAIST CIRCUMFERENCE;

EID: 84885949578     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.08.006     Document Type: Article

References (31)

1. Henseler T., Christophers E. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. JAm Acad Dermatol 1985, 13(3):450-456.
2. Ferrandiz C., Pujol R.M., Garcia-Patos V., Bordas X., Smandía J.A. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. JAm Acad Dermatol 2002, 46(6):867-873.
3. Allen M.H., Ameen H., Veal C., Evans J., Ramrakha-Jones V.S., Marsland A.M., et al. The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis. JInvest Dermatol 2005, 124(1):103-106.
4. Ejaz A., Raza N., Iftikhar A., Farooq M. Presentation of early onset psoriasis in comparison with late onset: a clinical study from Pakistan. Indian J Dermatol Venereol Leprol 2009, 75(1):36-40.
5. Gupta M.A., Gupta A.K., Watteel G. Early onset (<40 years age) psoriasis is comorbid with greater psychopathology than late onset psoriasis: a study of 137 patients. Acta Derm Venereol 1996, 76(6):464-466.
6. Mallbris L., Larsson P., Bergqvist S., Vingard E., Granath F., Stahle M. Psoriasis phenotype at disease onset: clinical characterization of 400 adult cases. JInvest Dermatol 2005, 124(3):499-504.
7. Youn J.I., Park B.S., Park S.B., Kim S.D., Suh D.H. Characterization of early and late onset psoriasis in the Korean population. JDermatol 1999, 26(10):647-652.
8. Gudjónsson J.E., Kárason A., Rúnarsdóttir E.H., Antonsdóttir A.A., Hauksson V.B., Jonsson H.H. Distinct clinical differences between HLA-Cw>0602 positive and negative psoriasis patients-an analysis of 1019 HLA-C and HLA-B-typed patients. JInvest Dermatol 2006, 126(4):740-745.
9. Gudjónsson J.E., Kárason A., Antonsdóttir A.A., Rúnarsdóttir E.H., Gulcher J.R., Stefánsson K. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. JInvest Dermatol 2002, 118(2):362-365.
10. Augustin M., Reich K., Glaeske G., Schaefer I., Radtke M. Comorbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010, 90(2):147-151.
11. Langan S.M., Seminara N.M., Shin D.B., Troxel A.B., Kimmel S.E., Mehta N.N. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. JInvest Dermatol 2012, 132(3 Pt 1):556-562.
12. Persson P.G., Leijonmarck C.E., Bernell O., Hellers G., Ahlbom A. Risk indicators for inflammatory bowel disease. Int J Epidemiol 1993, 22(2):268-272.
13. Cohen M.R., Reda D.J., Clegg D.O. Baseline relationships between psoriasis and psoriatic arthritis: analysis of 212 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. JRheumatol 1999, 26(8):1752-1756.
14. Gupta M.A., Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis, and psoriasis. Br J Dermatol 1998, 139(5):846-850.
15. Mrowietz U., Kraqballe K., Reich K., Spuls P., Griffiths C.E., Nast A. Definition of treatment goals for moderate to severe psoriasis: a European consensus. Arch Dermatol Res 2011, 303(1):1-10.
16. Han T.S., van Leer E.M., Seidell J.C., Lean M.E. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995, 311(7017):1401-1405.
17. Raychaudhuri S.P., Gross J. Acomparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000, 17(3):174-178.
18. de Jager M.E., de Jong E.M., Meeuwis K.A., van de Kerkhof P.C., Seyger M.M. No evidence found that childhood onset of psoriasis influences disease severity, future body mass index or type of treatments used. JEur Acad Dermatol Venereol 2010, 24(11):1333-1339.
19. Henseler T., Christophers E. Disease concomitance in psoriasis. JAm Acad Dermatol 1995, 32(6):982-986.
20. Sterry W., Strober B.E., Menter A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007, 157(4):649-655.
21. Setty A.R., Curhan G., Chol H.K. Obesity, waist circumference, weight change, and the risk of psoriasis in women. Nurses' Health Study II. Arch Intern Med 2007, 167(15):1670-1675.
22. Duarte G.V., Oliveira Mde F., Cardoso T.M., Follador I., Silva T.S., Cavalheiro C.M., et al. Association between obesity measured by different parameters and severity of psoriasis. Int J Dermatol 2013, 52(2):177-181.
23. Nijsten T., Wakkee M. Complexity of the association between psoriasis and comorbidities. JInvest Dermatol 2009, 129(7):1601-1603.
24. Herron M.D., Hinckley M., Hoffman M.S., Papenfuss J., Hansen C.B., Callis K.P., et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005, 141(12):1527-1534.
25. Wolk K., Mallbris L., Larsson P., Rosenblad A., Vingard E., Stahle M. Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis. Acta Derm Venerol 2009, 89(5):492-497.
26. Queiro R., Tejón P., Coto P., Alonso S., Alperi M., Sarasqueta C., et al. Clinical differences between men and women with psoriatic arthritis: relevance of theanalysis of genes and polymorphisms in the major histocompatibility complex region and of the age at onset of psoriasis. Clin DevImmunol 2013, 2013:482691. Epub2013 Apr16. 10.1155/2013/482691.
27. Gladman D.D., Cheung C., Nq C.M., Wade J.A. HLA-C locus alleles in patients with psoriatic arthritis (PsA). Hum Immunol 1999, 60(3):259-261.
28. Anandarajah A.P., Ritchlin C.T. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol 2004, 16(4):338-343.
29. Schmitt J., Ford D.E. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. JEur Acad Dermatol Venereol 2010, 24(8):885-892.
30. Kurd S.K., Troxel A.B., Crits-Christoph P., Gelfand J.M. The risk of depression, anxiety, and suicidality in patient with psoriasis: a population-based cohort study. Arch Dermatol 2010, 146(8):891-895.
31. Lysell J., Padyukov L., Kockum I., Nikamo P., Stahle M. Genetic association with ERAP1 in psoriasis is confined to disease onset after puberty and not dependent on HLA-C>06. JInvest Dermatol 2013, 133(2):411-417.